Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (4): 357-361.DOI: 10.3969/j.issn.1673-8640.2021.04.001
Received:
2020-03-07
Online:
2021-04-30
Published:
2021-04-28
Contact:
WANG Lei
CLC Number:
WANG Wei, WANG Lei. Influence of pre-analysis factors on clinical biochemical test results[J]. Laboratory Medicine, 2021, 36(4): 357-361.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.04.001
[1] | 丛玉隆, 尹一兵, 陈瑜. 检验医学高级教程[M]. 2版. 北京: 人民军医出版社, 2010. |
[2] | 李亚菊, 张晨, 陈锟. 分析前因素对血乳酸检测结果的影响[J]. 检验医学与临床, 2017,14(Z2):48-51. |
[3] | 白巨明. 样本放置时间及温度对血氨检测结果的影响[J]. 检验医学与临床, 2015,12(19):2941-2942. |
[4] | 全国卫生专业技术资格考试专家委员会. 临床医学检验技术(师)[M]. 北京: 人民卫生出版社, 2010. |
[5] | 张寅珊. 血液样本放置时间对血糖检测结果的影响[J]. 健康之路, 2016,15(3):249-250. |
[6] |
NARAYANAN S. The preanalytic phase an important component of laboratory medicine[J]. Am J Clin Pathol, 2000,113(3):429-452.
DOI URL PMID |
[7] |
TURCHIANO M, NGUYEN C, FIERMAN A, et al. Impact of blood sample collection and processing methods on glucose levels in community outreach studies[J]. J Environ Public Health, 2013,2013:256151.
DOI URL PMID |
[8] | 廖静, 丁霏, 罗薇, 等. 住院患者低血糖症的病因分析及鉴别方法初探[J]. 国际检验医学杂志, 2020,41(2):205-208. |
[9] | 夏良裕, 徐二木, 曹新策, 等. 溶血对41个生化免疫项目的影响评估及溶血警告指数的确立[J]. 中华检验医学杂志, 2017,40(12):947-952. |
[10] | 彭凤, 徐晓萍, 王琳, 等. 免疫透射比浊法和免疫散射比浊法检测特定蛋白的抗干扰能力比较[J]. 检验医学, 2013,28(2):142-145. |
[11] |
JI J Z, MENG Q H. Evaluation of the interference of hemoglobin,bilirubin,and lipids on Roche Cobas 6000 assays[J]. Clin Chim Acta, 2011,412(17-18):1550-1553.
DOI URL PMID |
[12] | 孙虹, 牛华, 赵崇吉, 等. 胆红素、血红蛋白和乳糜微粒对生化检测结果的干扰评价[J]. 国际检验医学杂志, 2011,32(21):2509-2512. |
[13] | 陈池华. 溶血对临床尿酸检测的影响及评价[J]. 医学检验与临床, 2015,26(3):75-76. |
[14] | 郭洪晨, 刘静. 胆红素对临床检验结果的干扰及消除[J]. 检验医学与临床, 2009,6(18):1573-1575. |
[15] | 王缚鲲, 王宪灵, 安黎云, 等. 各种胆红素对氧化酶法测定血清尿酸浓度的影响[J]. 检验医学, 2005,20(1):4-6. |
[16] |
AOKI Y, IHARA H, NAKAMURA H, et al. Effects of serum bilirubin on determination of uric acid by the uricase-peroxidase coupled reaction[J]. Clin Chem, 1992,38(7):1350-1352.
URL PMID |
[17] | 刘蕊, 李刚, 崔小璠. 胆红素和血红蛋白对不同尿白蛋白检测方法结果干扰的研究[J]. 检验医学, 2012,27(7):564-567. |
[18] |
SIMONSON P D, KIM K H, WINSTON-MCPHERSON G, et al. Characterization of bilirubin interference in three commonly used digoxin assays[J]. Clin Biochem, 2019,63:102-105.
DOI URL PMID |
[19] | 孟凡超, 赵宗玲, 张梅, 等. 三酰甘油对临床生化检查的干扰剂量效应分析[J]. 检验医学与临床, 2014,11(18):2526-2528. |
[20] | 宋霖, 戴雯, 张宁. 高浓度三酰甘油对免疫比浊法检测项目的影响[J]. 国际检验医学杂志, 2019,40(10):1236-1239. |
[21] |
OHTAKE T, KANO S, WATANABE K. Interference in turbidimetric immunoassay for serum C-reactive protein due to serum protein abnormalities an immune complex and rheumatoid factor[J]. Rinsho Byori, 2000,48(8):752-759.
URL PMID |
[22] |
KITAAKI S, HAYASHI N, SATO I, et al. Factors affecting non-specific reaction in latex agglutination turbidimetric immunoassay for detection of matrix metalloproteinase-3[J]. Rinsho Byori, 2015 , 63(4):427-434.
URL PMID |
[23] | 黄佳芝, 徐萍, 刘宇嘉. 类风湿因子干扰免疫比浊法测定胱抑素 C 的原因(1例)[J]. 医疗装备, 2017,30(17):58-59. |
[24] |
WU X Y, YIN Y F, TENG J L, et al. IgMκ paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay:a case report[J]. BMC Immunol, 2017,18(1):32.
DOI URL PMID |
[25] | HIRATA K, SARUWATARI J, ENOKI Y, et al. Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM[J]. Ther Drug Monit, 2014,36:553-555. |
[26] | 韩建华, 程歆琦, 吴洁, 等. M蛋白对免疫透射比浊法和免疫散射比浊法检测免疫球蛋白的干扰[J]. 检验医学, 2019,34(3):197-201. |
[27] | 杨杰, 李茂城, 尹小毛, 等. 27项特定蛋白项目检测结果分析及钩状效应的防范方法[J]. 检验医学与临床, 2019,16(1):8-12. |
[28] | 张杰良, 黄雪珍, 莫和国, 等. 尿微量清蛋白抗原再添加检测技术与前带检查研究分析[J]. 重庆医学, 2017,46(28):3962-3964. |
[29] |
SENA S F, SYED D, ROMEO R, et al. Lidocaine metabolite and creatinine measurements in the Ektachem 700:steps to minimize its impact on patient care[J]. Clin Chem, 1988,34(10):2144-2148.
URL PMID |
[30] | GUO X, HOU L, CHENG X, et al. Strong negative interference by calcium dobesilate in sarcosine oxidase assays for serum creatinine involving the Trinder reaction[J]. Medicine(Baltimore), 2015,94(23):e905. |
[31] | 余久如, 潘桂红, 鞠萍, 等. 羟苯磺酸钙对肌氨酸氧化酶法检测肌酐的干扰[J]. 中华检验医学杂志, 2013,36(2):161-164. |
[32] |
PETRIDES A K, NESS M A, JUDGE D P, et al. Fluctuating creatinine in the cardiac unit[J]. Clin Chim Acta, 2015,447:52-54.
DOI URL PMID |
[33] |
SAENGER A K, LOCKWOOD C, SNOZEK C L, et al. Catecholamine interference in enzymatic creatinine assays[J]. Clin Chem, 2009,55(9):1732-1736.
DOI URL PMID |
[34] | 从玉隆, 杨建良. 大剂量青霉素对尿蛋白定性结果影响的探讨[J]. 中华检验医学杂志, 1994,17(3):167-168. |
[35] | 张俊, 周芳芳, 徐玮, 等. 干化学法检测尿蛋白的影响因素分析[J]. 检验医学, 2018,33(10):916-919. |
[36] | 李自越, 白重阳, 沈建军, 等. 注射用头孢替安对钒酸盐氧化法和干化学法测定的总胆红素浓度的影响[J]. 国际检验医学杂志, 2016,37(9):1197-1199. |
[37] | 龙宪连, 刘晨, 于敏, 等. 头孢替安对总胆红素测定的干扰作用分析[J]. 中华检验医学杂志, 2010,33(8):761-763. |
[1] | WANG Chao, ZHAO Yu. Research progress on formation mechanism and eradication strategy of bacterial persisters [J]. Laboratory Medicine, 2023, 38(8): 790-795. |
[2] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[3] | MA Dongmei, JIANG Dongkui, XIANG Xiaobo, LI Shiliang. Antibacterial activity of 4 Chinese herbal medicines alone and combined with western medicines for extensively drug resistant Acinetobacter baumannii [J]. Laboratory Medicine, 2023, 38(5): 441-445. |
[4] | FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361. |
[5] | WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying. Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing [J]. Laboratory Medicine, 2023, 38(4): 362-367. |
[6] | DENG Jin, LIU Ya, WU Siying, LIAO Quanfeng, ZHANG Weili, XIAO Yuling, XIE Yi, MA Ying, KANG Mei. Antimicrobial drugs combined with drug susceptibility test in vitro [J]. Laboratory Medicine, 2023, 38(4): 385-393. |
[7] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[8] | REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin. Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit [J]. Laboratory Medicine, 2023, 38(2): 157-162. |
[9] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[10] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[11] | RU Haohao, CHEN Lianyong, YANG Xing, CHEN Tao, YAN Shuangqun, XU Lin. Analysis of rifampicin resistance in Mycobacterium tuberculosis determined by Xpert MTB/RIF and phenotypic drug susceptibility test [J]. Laboratory Medicine, 2023, 38(11): 1032-1035. |
[12] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[13] | HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891. |
[14] | XU Qi, PAN Fen, SUN Yan, SHI Yingying, YU Fangyuan, ZHANG Hong. Methodology evaluation of screening techniques for CRE colonized in intestinal tract [J]. Laboratory Medicine, 2022, 37(8): 761-765. |
[15] | WAN Changchun, YANG Hui, ZHUANG Xuewei. Application of polymerase chain reaction melting curve method in determining hypertensive drug-related gene mutations [J]. Laboratory Medicine, 2022, 37(7): 646-651. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||